# Co-existence of fibroadenoma, intraductal carcinoma and invasive ductal carcinoma in the unilateral breast mass: a case report and literature review

**Authors:** Sha Zhong, Hui Xu, Xuan Ye, Yi Xu, Zhe Fan

PMC · DOI: 10.3389/fonc.2026.1727815 · Frontiers in Oncology · 2026-02-19

## TL;DR

A rare case of a breast mass containing both benign and cancerous tumors is reported, emphasizing the need for thorough evaluation and accurate diagnosis.

## Contribution

This case report highlights the rare coexistence of fibroadenoma, DCIS, and IDC in a unilateral breast mass.

## Key findings

- A 71-year-old woman had a breast mass containing IDC, DCIS, and fibroadenoma.
- The tumors showed Luminal B1 subtype with ER and PR positivity and Her-2 negativity.
- The patient completed treatment with no recurrence observed during follow-up.

## Abstract

Fibroadenoma is the most common benign breast tumor. However, the coexistence of ductal carcinoma in situ (DCIS) and invasive ductal carcinoma (IDC) within single breast fibroadenomas is rare.

A 71-year-old woman presented with a palpable mass in her left breast, and she had a history of right-side breast cancer, which had been treated 16 years ago. Invasive ductal carcinoma was confirmed through core needle biopsy. She subsequently underwent left breast mastectomy with sentinel lymph node biopsy. Postoperative pathological examination revealed two fibroadenomas: the larger one coexisted with IDC and focal DCIS, and the small one coexisted with high-grade DCIS. Immunohistochemical analysis showed positive expression of estrogen receptor (ER) and progesterone receptor (PR), but negative expression of Her-2, demonstrating a Luminal B1 subtype (clinical stage IA). She had completed the adjuvant chemotherapy and currently received endocrine therapy. No recurrence was found during the follow-up examinations.

Coexistence of fibroadenoma, DCIS and IDC in unilateral breast mass is rare, highlighting the importance of comprehensive preoperative evaluation, optimal surgical strategy and accurate histopathological examination.

## Linked entities

- **Proteins:** ERBB2 (erb-b2 receptor tyrosine kinase 2)
- **Diseases:** fibroadenoma (MONDO:0002056), ductal carcinoma in situ (MONDO:0005023), invasive ductal carcinoma (MONDO:0004953), breast cancer (MONDO:0004989)

## Full-text entities

- **Genes:** TP63 (tumor protein p63) [NCBI Gene 8626] {aka AIS, B(p51A), B(p51B), EEC3, KET, LMS}, EREG (epiregulin) [NCBI Gene 2069] {aka EPR, ER, Ep}, PGR (progesterone receptor) [NCBI Gene 5241] {aka NR3C3, PR}, APC (APC regulator of Wnt signaling pathway) [NCBI Gene 324] {aka BTPS2, DESMD, DP2, DP2.5, DP3, GS}, RASSF1 (Ras association domain family member 1) [NCBI Gene 11186] {aka 123F2, NORE2A, RASSF1A, RDA32, REH3P21}, ERBB2 (erb-b2 receptor tyrosine kinase 2) [NCBI Gene 2064] {aka CD340, HER-2, HER-2/neu, HER2, MLN 19, MLN-19}, ESR1 (estrogen receptor 1) [NCBI Gene 2099] {aka ER, ESR, ESRA, ESTRR, Era, NR3A1}
- **Diseases:** Breast fibroadenoma (MESH:D061325), LCIS (MESH:D000071960), hypertension (MESH:D006973), metastasis (MESH:D009362), lobular carcinoma (MESH:D018275), carcinoma in situ (MESH:D002278), cancer (MESH:D009369), DCIS (MESH:D002285), carcinogenesis (MESH:D063646), benign breast tumor (MESH:D001943), IDC (MESH:D044584), invasive carcinoma (MESH:D009361), unilateral breast mass (MESH:D000069584), IA (MESH:C536041), mass (MESH:C536030), benign breast diseases (MESH:D001941), Fibroadenoma (MESH:D018226), carcinomatous (MESH:D055756)
- **Chemicals:** letrozole (MESH:D000077289), TC (MESH:D013667), ADM (MESH:D004317), paraffin (MESH:D010232), paclitaxel (MESH:D017239), 5-FU (MESH:D005472), irbesartan (MESH:D000077405), CTX (MESH:D003520), amlodipine besylate (MESH:D017311)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12960149/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12960149/full.md

## References

19 references — full list in the complete paper: https://tomesphere.com/paper/PMC12960149/full.md

---
Source: https://tomesphere.com/paper/PMC12960149